US 7718629
Compositions and methods for inhibiting expression of Eg5 gene
granted A61PA61P35/00A61P43/00
Quick answer
US patent 7718629 (Compositions and methods for inhibiting expression of Eg5 gene) held by Alnylam Pharmaceuticals, Inc. expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61P, A61P35/00, A61P43/00